Stock Analysis
Linde plc Ordinary ShareLIN
P/E 31.72×· 5Y range 25.99–50.66×· bottom 14% of history
Sector: Basic Materials · Industry: Industrial Inorganic Chemicals
AnalystsStrong Buy31 analystsP/E 31.7× sits at the 14th percentile of its 5.0978781656399725-year history.
Cash covers 20% of debt · FY 2025.
PMP Verdict
Strong business, attractive price
Strengths
- Profitability82
- Quality75
High-quality business at an attractive price.
Bull Case
- ✓Altman Z 4.0 — safe-zone balance sheet
- ✓ROE 18.9% — efficient capital deployment
- ✓Interest coverage 34.4× — debt well covered
- ✓P/E 31.7× at bottom 14% of 5-year history
What's happening with LIN
Profile
Strong profitability and earnings quality; moat and valuation lag behind.
How is each axis scored?
- Valuation47/100 · Weak
- P/E vs own history (14th pct)25/25
- FCF yield (2.2%)5/25
- P/S (6.4x)12/25
- EV/EBIT (26.5x)5/25
- Growth66/100 · Moderate
- Revenue CAGR (2.5%)6/25
- Net income CAGR (15.9%)20/25
- EPS CAGR 5Y (18.8%)20/25
- Fwd implied growth (29.3%)20/25
- Profitability82/100 · Strong
- ROIC (12.7%)12/25
- ROE (18.9%)20/25
- Net margin (20.4%)25/25
- Operating margin (26.5%)25/25
- Financial Health68/100 · Moderate
- Altman Z (3.96)25/25
- Current ratio (0.88)6/25
- Interest coverage (34.4x)25/25
- Net cash / debt (D/A 23%)12/25
- Quality75/100 · Strong
- Piotroski F (5/9)15/25
- Beneish M (-2.70)25/25
- FCF conversion (69%)15/25
- Margin stability (σ 7.3%)20/25
- Moat43/100 · Weak
- ROIC >12% years (2/8 yrs)0/25
- Median gross margin (n/a)0/25
- FCF-positive years (8/8 yrs)25/25
- Worst-year net margin (worst 8.1%)18/25
About Linde plc Ordinary Share
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. Show more
The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $34 billion in revenue in 2025.
Headquarters: WOKING SURREY, X0 · Employees: 64,649 · Website ↗
Price History
Weekly Candlestick Chart — up to 5Y
Key Metrics
Financial snapshot · Tap any metric for its definition and grade
TTM Snapshot
trailing twelve months · YoYValuation
47D+P/E (TTM)31.6xC
Grade C: ExpensivePrice / TTM EPS (own statements) — vs own 5Y history: 26.0x–50.7x · 14th pct
P/FCF45.7xD
Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
FCF Yield2.2%C
Grade C: LowTTM (OCF − CapEx) / Market Cap — vs own 5Y history: 2.0%–5.1% · 8th pct · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
P/S (TTM)6.45xC
Grade C: ExpensivePrice / TTM Revenue (own statements) — vs own 5Y history: 4.0x–7.2x · 65th pct
EV/EBIT26.5xD
Grade D: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 22.2x–40.8x · 17th pct
EV/Sales7.1xC
Grade C: ExpensiveEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E24.4xB
Grade B: FairPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio5.98xC
Grade C: ExpensivePrice to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.54D
Grade D: ExpensiveFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield1.27%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio39.7%A
Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Elevated investment: Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Profitability
82AROIC12.7%C
Grade C: AverageNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE18.9%C
Grade C: AverageReturn on Equity. Neg. equity = heavy buybacks
ROA8.3%C
Grade C: AverageReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin20.4%A
Grade A: HighNet Income / Revenue
Operating Margin26.5%A
Grade A: HighTTM EBIT / TTM Revenue
Gross Margin48.4%C
Grade C: AverageGross Profit / Revenue
FCF Margin14.0%C
Grade C: AverageFCF / Revenue · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
True FCF Margin13.7%A
Grade A: HighTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Growth
66BRevenue CAGR2.5%D
Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR15.9%A
Grade A: HighCompound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)18.8%A
Grade A: HighCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Implied EPS Growth29.3%C
Grade C: MedAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth
Dilution (5Y)-12.3%A
Grade A: BuybacksShare count change over 5Y
SBC / Net Income1.9%A
Grade A: LowStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.4%A
Grade A: LowTTM stock-based comp / TTM Revenue
Financial Health
68BAltman Z-Score3.96A
Grade A: SafeBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.88xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.68xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage34.4xA
Grade A: StrongEBIT/Interest. >10 Strong
Debt Repayment4.0yC
Grade C: AverageYears to repay net debt via FCF · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Net Debt/EBIT2.1xC
Grade C: MedLeverage. <2x Low, >4x High
Debt/Equity0.66xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt0.20xD
Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash
Quality
75B+Piotroski F-Score5/9C
Grade C: AverageFinancial strength 0–9. >7 Strong
Beneish M-Score-2.70A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion68.7%C
Grade C: AverageFCF / Net Income · Elevated investment — CapEx = 53% of operating cash flow, weighing on reported FCF
Margin Stability7.3%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue15.6%D
Grade D: HeavyTTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.41xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Insider Transactions
SEC Form 4 · 8 recordsP/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Reynolds Paula Rosput Filed | Reynolds Paula Rosput | Grant / award | +18 | |
GRANT HUGH Filed | GRANT HUGH | Grant / award | +72 | |
Reynolds Paula Rosput Filed | Reynolds Paula Rosput | BuyOpen market buy | +100 | |
Reynolds Paula Rosput Filed | Reynolds Paula Rosput | Grant / award | +16 | |
GRANT HUGH Filed | GRANT HUGH | Grant / award | +64 |
Show 3 more filingsShow fewer filings
| Trade date | Insider | Transaction | Shares | Filed |
|---|---|---|---|---|
Innocenzi Stefanos Filed | Innocenzi Stefanos | Option exercise | -4035 | |
Innocenzi Stefanos Filed | Innocenzi Stefanos | Tax withholding | -2062 | |
Innocenzi Stefanos Filed | Innocenzi Stefanos | Option exercise | +4.0K |
Option exercise (M) rows report a derivative leg, not an open-market sale — a paired negative entry is the option position being consumed.
More metrics — Moat, Per Share, Balance Sheet, MarketHide additional metrics
Moat
43D+ROIC >12% Years2/8 yrsD
Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability
Gross Margin (Med.)—
Median annual gross margin across available fiscal years — pricing-power durability
FCF-Positive Years8/8 yrsA
Grade A: DurableShare of completed fiscal years with positive free cash flow
Net Margin Floor8.1%A
Grade A: DurableWeakest annual net margin across completed fiscal years — recession/downcycle resilience
Per Share
EPS (TTM)$15.71
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$10.63
Cash & short-term investments per share (Finnhub)
Book Value / Share$84.78
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt$25.19B
Total debt obligations (short + long term)
Cash & Equiv.$5.06B
Cash and short-term investments
Net Debt$20.14B
Total Debt minus Cash. Negative = Net Cash position
Total Equity$38.24B
Shareholders' equity (book value)
Asset / Liability1.84xC
Grade C: AdequateTotal Assets / Total Liabilities
Market
Market Cap$228.57B
Current Market Capitalization
Beta0.70B
Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026
Key Insights: Linde plc Ordinary Share (LIN)
LIN is up 1.06% at the last close. Piotroski F-Score of 5/9 indicates mixed fundamentals for Linde plc Ordinary Share. Altman Z-Score of 3.96 sits comfortably in the safe zone (≥ 2.99), indicating low bankruptcy risk.
- Beneish M-Score of -2.70 suggests a low likelihood of earnings manipulation.
- Takes ~4.0 years to repay net debt from free cash flow.
See how LIN ranks on the Capex Tracker — top 50 capital spenders compared.
Recent Market Moves
See all LIN moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Oct 2 | Regular | 479.30 | +2.10% | 2.62 |
| Oct 2 | After-hours | 481.25 | +2.51% | 3.11 |
| Sep 22 | Regular | 465.70 | +1.79% | 2.95 |
| Sep 22 | After-hours | 465.10 | +1.66% | 2.77 |
Frequently Asked Questions about LIN
What is the current Linde plc Ordinary Share (LIN) stock price?
LIN is trading at $498.43 at the last market close, up 1.06% on the session. PreMarketPrice tracks LIN pre-market, intraday and after-hours prices.
Is LIN stock a buy right now?
PreMarketPrice's quantitative model rates Linde plc Ordinary Share's financial health at 68/100. This is a data-driven snapshot of fundamentals, not investment advice.
Is LIN stock overvalued?
Linde plc Ordinary Share trades at a trailing P/E of 31.6 and our valuation score rates it 47/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does Linde plc Ordinary Share report earnings?
No confirmed earnings date is currently scheduled for LIN. The Earnings section lists recent reports and updates as dates are announced.
What sector does Linde plc Ordinary Share operate in?
Linde plc Ordinary Share operates in the Basic Materials sector, within the Industrial Inorganic Chemicals industry. The Related Stocks section lists sector peers for comparison.
What does Linde plc Ordinary Share do?
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries.
About Linde plc Ordinary Share (LIN) Stock
Linde plc Ordinary Share (LIN) is a US-listed stock operating in the Basic Materials sector, specifically the Industrial Inorganic Chemicals industry. As of the latest update, Linde plc Ordinary Share is trading at $498.43, up 1.06% on the day with a market capitalization of $228.6 billion. The financial health score for LIN is 68/100, which indicates good financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for LIN stock.
LIN Stock Analysis & Key Metrics
On PreMarketPrice, you can track Linde plc Ordinary Share (LIN) across multiple dimensions:
- Pre-market price & movement: Real-time LIN stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for LIN with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for Linde plc Ordinary Share across multiple reporting periods.
- Financial health score: A composite score of 68/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for LIN.
- Sector peers: Compare LIN against 4 other basic materials stocks on key financial metrics.
Is LIN a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate Linde plc Ordinary Share (LIN) as an investment. The financial health score of 68/100 suggests good financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Linde plc Ordinary Share (LIN) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.